Clinical Trials

Neoplasms, Prostatic Neoplasms

NCT05818683 2026-02-13

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer

Phase 1 Recruiting

277 enrolled

Metastatic Castration-resistant Prostate Neoplasms

NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Completed

1,083 enrolled 29 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT02985957 2025-12-22

CheckMate 650

351 enrolled 43 charts

Prostatic Neoplasms

NCT05005728 2025-07-17

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

72 enrolled

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06890832 2025-03-24

A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

75 enrolled

Metastatic Castration-resistant Prostate Cancer, MCRPC

NCT04495179 2023-08-09

AARDVARC

30 enrolled 22 charts

Prostatic Neoplasms

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT03419442 2020-10-22

Multi-academic Center Study of Xofigo Patients

Completed

150 enrolled

Prostatic Neoplasms

NCT02379390 2019-06-21

PRIMCAB

Phase 2 Terminated

8 enrolled 8 charts

Prostate Cancer Metastatic

NCT01308567 2019-06-05

FIRSTANA

1,168 enrolled 17 charts

Prostatic Neoplasms

NCT01718353 2017-11-20

TAXYNERGY

63 enrolled 13 charts

Prostate Cancer Metastatic

NCT01308580 2017-04-17

PROSELICA

1,200 enrolled 25 charts

Prostatic Neoplasms

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

21 enrolled

Prostatic Neoplasms

NCT01083615 2016-10-12

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Phase 3 Terminated

14 enrolled

Castrate-Resistant Prostate Cancer

NCT01578655 2016-10-12

AFFINITY

630 enrolled

Prostatic Neoplasms

NCT01447225 2016-09-14

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

43 enrolled 21 charts

Neoplasms

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Phase 1/2 Completed

39 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm

NCT01140607 2015-07-21

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

56 enrolled

Neoplasms

NCT01254279 2015-01-21

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

984 enrolled

Prostate Cancer Metastatic

NCT01576029 2013-12-24

SWITCH

2 enrolled

Prostatic Neoplasms

NCT01001221 2013-09-11

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Phase 1/2 Terminated

19 enrolled 55 charts

Neoplasms

NCT00925743 2013-05-16

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

76 enrolled

Solid Cancer

NCT01755390 2012-12-24

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

42 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT01087021 2011-12-16

QT-Cab

45 enrolled